Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
US Army
Cipla
UBS
QuintilesIMS
Fish and Richardson
Medtronic
Dow
Healthtrust
Chubb

Generated: February 25, 2018

DrugPatentWatch Database Preview

Hydrochlorothiazide; olmesartan medoxomil - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrochlorothiazide; olmesartan medoxomil and what is the scope of hydrochlorothiazide; olmesartan medoxomil freedom to operate?

Hydrochlorothiazide; olmesartan medoxomil
is the generic ingredient in two branded drugs marketed by Daiichi Sankyo, Alembic Pharms Ltd, Aurobindo Pharma Ltd, Mylan Pharms Inc, Prinston Inc, Teva Pharms Usa, and Torrent Pharms Ltd, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; olmesartan medoxomil. Fourteen suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for hydrochlorothiazide; olmesartan medoxomil
Pharmacology for hydrochlorothiazide; olmesartan medoxomil
Tentative approvals for HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up20MG;12.5MGTABLET;ORAL
➤ Sign Up➤ Sign Up40MG;25MGTABLET;ORAL
➤ Sign Up➤ Sign Up40MG;12.5MGTABLET;ORAL

US Patents and Regulatory Information for hydrochlorothiazide; olmesartan medoxomil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 078827-002 Oct 26, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 205391-002 Apr 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 200532-003 Apr 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 200532-001 Apr 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 078827-003 Oct 26, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Prinston Inc OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 207804-001 Apr 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alembic Pharms Ltd OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 204233-003 Apr 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Daiichi Sankyo BENICAR HCT hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 021532-005 Jun 5, 2003 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alembic Pharms Ltd OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 204233-001 Apr 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 205391-003 Apr 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for hydrochlorothiazide; olmesartan medoxomil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi Sankyo BENICAR HCT hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 021532-002 Jun 5, 2003 ➤ Sign Up ➤ Sign Up
Daiichi Sankyo BENICAR HCT hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 021532-003 Jun 5, 2003 ➤ Sign Up ➤ Sign Up
Daiichi Sankyo BENICAR HCT hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 021532-005 Jun 5, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Accenture
US Army
Healthtrust
McKesson
Julphar
Fish and Richardson
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot